The blood-brain barrier in multiple sclerosis

International Congress Series

Volumn 1277, Issue , 2005, Pages 235-243

  McQuaid, S ^a   Kirk, J ^b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Blood brain barrier; Immunofluorescence; Multiple sclerosis; Pathology; Tight junctions

Indexed keywords

EID: 33646454334     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2005.02.026     Document Type: Article

References (31)

1. Broman T. Blood-brain barrier damage in multiple sclerosis: supravital test observations. Acta Neurol. Scand. 40 suppl. 10 (1964) 21-24
2. Ebers G.C., et al. Multifocal CT enhancement in MS. Neurology 34 (1984) 341-346
3. Grossman R.I., et al. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 161 (1986) 721-725
4. Kermode A.G., Thompson A.J., and Tofts P. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: pathogenetic and clinical implications. Brain 113 (1990) 1477-1489
5. Katz D., et al. Correlation between magnetic resonance imaging findings and lesion development in chronic active multiple sclerosis. Ann. Neurol. 34 (1993) 661-669
6. Miller D.H., et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348 (2003) 15-23
7. Gay D., and Esiri M. Blood-brain barrier damage in acute multiple sclerosis plaques: an immunocytochemical study. Brain 114 (1991) 557-572
8. Richert N.D., et al. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Mult. Scler. 7 (2001) 49-58
9. Coles A.J., et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann. Neurol. 46 (1999) 296-304
10. Hickey W.F. The pathology of multiple sclerosis: a historical perspective. J. Neuroimmunol. 98 (1999) 37-44
11. Hemmer B., Archelos J., and Hartung H.-P. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev., Neurosci. 3 (2002) 291-301
12. Claudio L., Raine C.S., and Brosnan C.F. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol. 90 (1995) 228-238
13. Kraus J., et al. Interferon β stabilizes barrier characteristics of brain endothelial cells in vitro. Ann. Neurol. 56 (2004) 192-205
14. Ballabh P., Braun A., and Nedergaard M. The blood-brain barrier: an overview. Structure, regulation and clinical implications. Neurobiol. Dis. 16 (2004) 1-13
15. Bazzoni G., and Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol. Rev. 84 (2004) 869-901
16. Bauer H.-C., Traweger A., and Bauer H. Proteins of the tight junction in the blood-brain barrier. In: Sharma H.S., and Westman J. (Eds). Blood-spinal cord and brain barriers in health and disease (2004), Elsevier Academic Press, San Diego/London 1-10
17. Mayhan W.G. Regulation of blood-brain barrier permeability. Microcirculation 8 (2001) 89-104
18. Miller D.H., et al. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121 (1998) 3-24
19. Kwon E.E., and Prineas J.W. Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions: an immunohistochemical study. J. Neuropathol. Exp. Neurol. 53 (1994) 625-636
20. Plumb J., et al. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 12 (2002) 154-169
21. Kirk J., et al. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J. Pathol. 201 (2003) 319-327
22. Virgintino D., et al. Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem. Cell Biol. 122 (2002) 51-59
23. Steinman L., and Zamvil S. Transcriptional analysis of targets in multiple sclerosis. Nat. Rev., Immunol. 3 (2003) 483-492
24. Lee M.A., et al. Serum gelatinase-B, TIMP-1 and TIMP-2 levels in multiple sclerosis: a longitudinal clinical and MRI study. Brain 122 (1999) 191-197
25. Mayhan W.G. Cellular mechanisms by which tumour necrosis factor-α produces disruption of the blood-brain barrier. Brain Res. 927 (2002) 144-152
26. Kuruganti P.A., et al. Interferon-beta counteracts inflammatory mediator-induced effects on brain endothelial cell tight junction molecules-implications for multiple sclerosis. J. Neuropathol. Exp. Neurol. 61 (2002) 710-724
27. Petty M.A., and Lo E.H. Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol. 68 (2002) 311-323
28. Schmidt A., et al. Direct demonstration of association of the blood-brain barrier proteins ZO-1 and occludin using surface plasmon resonance spectroscopy: effect of SIN-1. In: Sharma H.S., and Westman J. (Eds). Blood-spinal cord and brain barriers in health and disease (2004), Elsevier Academic Press, San Diego/London 11-17
29. Silver N.C., et al. Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary study. Mult. Scler. 7 (2001) 75-82
30. Huber J.D., Egleton R.D., and Davis T.P. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24 (2001) 719-725
31. De Vries H.E., et al. The blood-brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 49 (1997) 143-155